By Ryan Davis ( August 21, 2014, 3:36 PM EDT) -- The Federal Circuit on Thursday affirmed a lower court ruling invalidating a Mathilda and Terence Kennedy Institute of Rheumatology Trust arthritis treatment patent for double-patenting, freeing AbbVie Inc. from having to license the patent for its blockbuster anti-inflammatory drug Humira....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.